Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

DocGo (DCGO) EBIT (2021 - 2025)

Historic EBIT for DocGo (DCGO) over the last 5 years, with Q3 2025 value amounting to -$42.0 million.

  • DocGo's EBIT fell 51407.38% to -$42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.9 million, marking a year-over-year decrease of 26917.78%. This contributed to the annual value of $28.7 million for FY2024, which is 9055.97% up from last year.
  • As of Q3 2025, DocGo's EBIT stood at -$42.0 million, which was down 51407.38% from -$17.5 million recorded in Q2 2025.
  • Over the past 5 years, DocGo's EBIT peaked at $15.9 million during Q1 2024, and registered a low of -$42.0 million during Q3 2025.
  • For the 5-year period, DocGo's EBIT averaged around $393612.8, with its median value being $1.6 million (2023).
  • As far as peak fluctuations go, DocGo's EBIT soared by 1447094.46% in 2023, and later plummeted by 51407.38% in 2025.
  • DocGo's EBIT (Quarter) stood at $15.5 million in 2021, then tumbled by 99.48% to $80116.0 in 2022, then skyrocketed by 14470.94% to $11.7 million in 2023, then plummeted by 164.02% to -$7.5 million in 2024, then tumbled by 461.69% to -$42.0 million in 2025.
  • Its EBIT was -$42.0 million in Q3 2025, compared to -$17.5 million in Q2 2025 and -$14.0 million in Q1 2025.